Other predictive biomarkers in nonsquamous NSCLC are the MET exon 14 skipping mutations [36,37], BRAF V600E mutation [38], ROS1 fusions [39] and RET fusions [40]. The gene discussed is MET; the disease is non-small cell lung carcinoma.